According to Sean Williams of the Motley Fool, these cannabis stocks should have at least 400% sales growth in fiscal 2019.
“The marijuana industry produced about as bifurcated a year as investors could have imagined in 2018. By the time the curtain closed, validity had been gained like never before, but pot stocks had been absolutely leveled.
On the bright side, Canada became the first industrialized country in the world to legalize recreational pot in October, with a handful of U.S. states choosing to give the green light to cannabis in some capacity in 2018. The U.S. Food and Drug Administration also approved its very first cannabis-derived drug. In other words, marijuana firmly shed its taboo label and became a legitimate business model last year.Unfortunately, that didn’t translate into gains for investors. Although pot stock shareholders were rewarded nicely in 2016 and 2017, most marijuana stocks shed 30%, 40%, or even more of their value, in 2018.”